feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Crime and Justice / J&J Talc Cancer Verdict: $65.5M Awarded

J&J Talc Cancer Verdict: $65.5M Awarded

20 Dec, 2025

•

Summary

  • A jury awarded $65.5 million to a mother with lung cancer.
  • She claimed talcum products caused her illness.
  • Johnson & Johnson plans to appeal the verdict.
J&J Talc Cancer Verdict: $65.5M Awarded

A Minnesota jury recently delivered a $65.5 million verdict in favor of a mother of three who alleged that Johnson & Johnson's talcum products led to her developing lung cancer. The plaintiff, Anna Jean Houghton Carley, 37, claimed prolonged use of the company's baby powder, including throughout her childhood, contributed to her mesothelioma, an aggressive cancer. Her legal team argued that Johnson & Johnson knew about the potential for asbestos contamination in its talc-based products but continued to market them without adequate warnings.

During a 13-day trial, Carley's attorneys presented evidence suggesting the pharmaceutical giant failed to inform consumers about the risks associated with their talc products. Johnson & Johnson, however, has maintained its baby powder is safe and free from asbestos, vowing to appeal the jury's decision. The company's worldwide vice president of litigation expressed confidence that an appellate court would overturn the verdict, dismissing the lawsuits as based on "junk science."

This judgment is the latest in a series of legal challenges against Johnson & Johnson regarding talc powder, with claims linking it to ovarian cancer and mesothelioma. The company has since ceased selling talc-based powders globally, with the U.S. market discontinuation occurring in 2020 and worldwide in 2023. Earlier verdicts this year also saw significant awards against the company in similar cases.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
A Minnesota jury determined that Johnson & Johnson's talcum products contributed to Anna Jean Houghton Carley developing lung cancer and awarded her $65.5 million.
Yes, Johnson & Johnson has stated its intention to appeal the recent $65.5 million verdict awarded to Anna Jean Houghton Carley in Minnesota.
Mesothelioma is an aggressive cancer primarily caused by asbestos exposure. Plaintiffs in talc lawsuits claim that asbestos contamination in talcum powder led to their development of this cancer.

Read more news on

Crime and Justiceside-arrow
trending

US India trade agreement

trending

T20: Cricket's World Cup thrives

trending

Karnataka dominates Mumbai in Ranji

trending

Munich Air Disaster remembered

trending

T20 World Cup 2026 schedule

trending

Siraj replaces injured Harshit Rana

trending

Barcelona vs Mallorca live stream

trending

Jio Hotstar viewership rises

trending

Newcastle lose to Brentford again

You may also like

McConaughey's Skin Ordeal: Mom's Product Caused Acne

16 hours ago • 4 reads

article image

Kimberly-Clark Beats Profit Estimates on Cost Cuts

27 Jan • 52 reads

article image

J&J Talc Lawsuits Get Expert Green Light

21 Jan • 42 reads

article image

Teva Loses Bid to Delay Paragard Lawsuit

13 Jan • 166 reads

article image

Supplements Recalled: Undeclared Drugs Found

11 Jan • 146 reads

article image